FirstWord

Researchers are now testing whether the tool can help primary care doctors spot which patients might need more heart testing.

The acquisition gives iRhythm immediate access to more of the $1-billion mobile cardiac telemetry market while its own next-generation product remains in development.

The drugs will be delivered to eligible patients' homes for free, with same-day service available across more than 3100 US cities and towns.

The biotechs are teaming up to discover new treatments for autoimmune and inflammatory diseases.

The deal adds a third disease setting to Hinge’s virtual care platform as the company expands beyond its original musculoskeletal care business.

University of Colorado Anschutz-led study shows automated oxygen system increases time in target oxygen range and reduces clinician workload compared with standard careAURORA, Colo., Aug. 3, 2026 /PRN...

Following the introduction of Invenia™ ABUS Prime at the Society of Breast Imaging Annual Symposium, the installation at BeSound in Los Angeles marks one of the first in the U.S., expanding access to ...

Company will present two scientific posters examining the operational and readiness applications of its tAN® platform, marking a key step in Spark's expansion into the military-ready and first respond...

Second Quarter Revenue Growth of 52% to $132 MillionRaises 2026 Revenue Guidance to $490 Million to $500 Million and Raises 2026 AEBITDA Guidance to $66 Million to $78 MillionBRISBANE, Calif.--(BUSINE...

Second quarter 2026 revenue growth of 44% driven by strong performance in Oncology and ScreeningRaises 2026 revenue guidance to $1.34 to $1.36 billion, representing growth of 36% to 38%PALO ALTO, Cali...